Welcome to LookChem.com Sign In|Join Free

CAS

  • or

105983-83-3

Post Buying Request

105983-83-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

105983-83-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 105983-83-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,9,8 and 3 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 105983-83:
(8*1)+(7*0)+(6*5)+(5*9)+(4*8)+(3*3)+(2*8)+(1*3)=143
143 % 10 = 3
So 105983-83-3 is a valid CAS Registry Number.

105983-83-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (723282)  N,N′-Di-Boc-N-methylethylenediamine  97%

  • 105983-83-3

  • 723282-1G

  • 196.56CNY

  • Detail
  • Aldrich

  • (723282)  N,N′-Di-Boc-N-methylethylenediamine  97%

  • 105983-83-3

  • 723282-5G

  • 920.79CNY

  • Detail

105983-83-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl N-methyl-N-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]carbamate

1.2 Other means of identification

Product number -
Other names N,N inverted exclamation marka-Di-Boc-N-methylethylenediamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:105983-83-3 SDS

105983-83-3Relevant articles and documents

COMPOSITIONS FOR REDUCING RISK OF ADVERSE EVENTS CAUSED BY DRUG-DRUG INTERACTIONS

-

, (2012/09/22)

The present disclosure provides a composition comprising a GABAA agonist and a GI enzyme inhibitor. The present disclosure also provides a composition comprising (a) a GI enzyme inhibitor and (b) a first drug that interacts with a second drug to produce an adverse effect when the second drug is co-ingested as a GI enzyme-cleavable prodrug with the first drug. Such an interaction can be additive or synergistic.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 105983-83-3